Biofrontera (BFRI) Net Equity Issued and Repurchased (2024)
Biofrontera (BFRI) posted quarterly Net Equity Issued and Repurchased of $7.7 million for Q1 2024.
Biofrontera (BFRI) Net Equity Issued and Repurchased (2024) Analysis & Trends
Biofrontera's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $7.7 million for Q1 2024.
- In Q1 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $7.7 million; the TTM figure through Dec 2024 stood at $7.7 million (changed N/A YoY), while the FY2024 annual figure was $7.7 million, up 70.0% from the prior year.
- Net Equity Issued and Repurchased for Q1 2024 stood at $7.7 million.
- The five-year high for Net Equity Issued and Repurchased was $7.7 million in Q1 2024, with the low at $7.7 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 7.66 Mn |
| Mar 31, 2024 | 7.66 Mn |